ImmuPharma "looking forward with quiet confidence" to FDA response | News Direct

ImmuPharma "looking forward with quiet confidence" to FDA response

ImmuPharma PLC
Digital Asset Direct by ImmuPharma PLC

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | May 24, 2023 11:08 AM Eastern Daylight Time

ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy visited Thomas Warner at Proactive's London studio to talk about the latest news on the specialty biopharmaceutical company's p140 platform. Immupharma recently announced that the US Food and Drug Administration (FDA) has endorsed the company's proposal for a late-stage clinical trial for the treatment of chronic idiopathic demyelinating polyneuropathy (CIDP), a rare neurological disorder.

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

project media

Tags

bio-techImmuPharmapharmaceuticalFDAproactiveinveststock